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1 These authors contribute equally to this work.THAP11 is an essential factor involved in ES cell pluripotency and cell growth. Here, we identiﬁed
THAP11 as a novel physiological binding partner of PCBP1. In HepG2 cells, THAP11 overexpression
inhibited CD44 v6 expression and cell invasion. However, when deleting the binding domain with
PCBP1 or endogenous PCBP1 was knocked down, THAP11 failed to inhibit CD44 v6 expression, indi-
cating that THAP11 regulates CD44 v6 expression through interacting with PCBP1. In HCC patients,
the expression of THAP11 mRNA signiﬁcantly correlated with PCBP1 mRNA expression. Our results
suggest a novel role of THAP11 in CD44 alternative splicing and hepatoma invasion.
Structured summary of protein interactions:
THAP11 physically interacts with PCBP1 by anti bait coimmunoprecipitation (View interaction)
THAP11 physically interacts with PCBP1 by anti tag coimmunoprecipitation (View Interaction: 1, 2)
THAP11 and PCBP1 colocalize by ﬂuorescence microscopy (View interaction)
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Thanatos-associated proteins (THAPs) are zinc-dependent,
sequence-speciﬁc DNA-binding factors involved in cell prolifera-
tion, apoptosis, chromatin modiﬁcation and transcriptional regula-
tion [1–4]. THAP11, the most recently described member of this
human protein family, is ubiquitously expressed in normal tissues
and frequently down-regulated in several human tumor tissues.
Enforced expression of THAP11markedly inhibits growth of a num-
ber of different cells including cancer cells and non-transformed
cells. Silencing of THAP11 by RNA interference in HepG2 cells result
in loss of cell growth repression, and this function of THAP11 is
partly mediated by its ability to bind to the c-myc promoter and
repress transcription of c-Myc [5]. Overexpression of THAP11chemical Societies. Published by E
e of Radiation Medicine, 27
8214653.
Li), xiaomingyang@sina.cominhibited CML cell proliferation [6]. These data suggest that THAP11
is a cell growth suppressor. Based on polymorphism and protein-
folding simulation studies, THAP11was suggested as a putative can-
didate for polyglutamine disorders [7]. The homolog of THAP11 in
mouse, Ronin, plays an essential role in embryogenesis and ES cell
pluripotency [8]. Conditional knockout of Ronin prevents the
growth of ES cellswhile enforced expression of Ronin allows ES cells
to proliferatewithout differentiation. ChIP-seq analysis suggest that
Ronin binds with Hcf-1 to a highly conserved enhancer element
located at or immediately upstream of transcription start sites of a
subset genes involved in transcription initiation, mRNA splicing,
and cell metabolism [9]. These studies suggested that THAP11 is a
multi-functional protein which still remains largely unknown. To
further explore the biological functions of THAP11, previously we
performed a yeast two-hybrid screening using a human fetal liver
cDNA library. PolyC-binding protein 1 (PCBP1or hnRNP E1) was
identiﬁed as an interacting substrate for THAP11.
PCBP1, a member of the PCBPs family, is widely expressed in
many human tissues and involved in regulation of transcription,
transportation process, and function of RNA molecules [10–13].lsevier B.V. All rights reserved.
Fig. 1. Conﬁrmation of the interaction between THAP11 and PCBP1. (A) HEK293 cells were co-transfected with the vectors as indicated and after 24 h, cells were harvested,
treated with RNase and DNase and subjected to immunoprecipitation with anti-Myc antibody and immunoblotted with antibodies indicated. (B) HepG2 cell lysates were
subjected to immunoprecipitations anti-THAP11 antibody using normal sheep IgG as control in the presence of RNase A and DNase I. (C) HepG2 cells were co-transfected
with THAP11-GFP and PCBP1-RFP for 24 h. Nucleus was stained with Hoechst 33258. The locations of THAP11 (green) and PCBP1 (red) were observed through confocal
imaging.
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CD44 alternative splicing in human hepatoma cell line HepG2 cells,
and loss of PCBP1 in human hepatocellular carcinoma (HCC) con-
tributes to the formation of a metastatic phenotype [14].
Since THAP11 and PCBP1 are both down-regulated in human
HCC tissues, it is easy to ask whether THAP11 regulates the CD44
alternative splicing and hepatoma metastasis just as PCBP1 does.
In the present study, we conﬁrmed the interaction between
THAP11 and PCBP1. We found that overexpression of THAP11
inhibited the CD44 v6 expression and cell invasion in HepG2 cells.
However, when deleting the binding domain with PCBP1 or endog-
enous PCBP1 was knockdown, THAP11 failed to inhibit CD44 v6
expression, indicating that THAP11 regulates the CD44 v6 expres-
sion through interacting with PCBP1. Importantly, the expression
of THAP11 mRNA was signiﬁcantly correlated with PCBP1 mRNA
expression in HCC patients. Our results suggest a novel role of
THAP11 in CD44 alternative splicing and HCC.
2. Materials and methods
2.1. Tissue specimens
All human hepatocellular carcinoma (HCC) specimens were ob-
tained from those patients who underwent surgical resection of
their diseases and were informed consent before operation on theirliver. The primary tumor specimens were immediately frozen at
80 C until RNA extraction. Both tumor and adjacent non-tumor
tissues were sampled respectively, with approximate 1 cm3
size of each specimen, and were proved by pathological
examination.
2.2. Plasmid constructions
The human full-length THAP11 and PCBP1 were ampliﬁed by
PCR from the human liver cDNA and cloned into the pcDNA3.1/
Myc-HisB or pCMV-Flag vector (Invitrogen, Carlsbad, CA, USA).
The resulting plasmid was sequenced and used for all subsequent
cloning. The THAP11 and PCBP1 deletion constructs were gener-
ated through ligation of PCR products ampliﬁed from the pcDNA3.1
(His/Myc)-THAP11 or pCMV-Flag-PCBP1. For subcellular localiza-
tion assays, THAP11 cDNA was cloned into pEGFP-N1 (Clontech,
Palo Alto, CA) and PCBP1 cDNA was cloned into pDsRed1-N1
(Clontech).
2.3. Cells and transfection
Human hepatoma cell line HepG2 cells, and human fetal kidney
cell line HEK293 cells were maintained in Dulbecco’s modiﬁed Ea-
gle’s medium (Gibco Invitrogen, CA) supplemented with 10% fetal
bovine serum at 37 C in 5% humidiﬁed CO2. DNA transfection
Fig. 2. Mapping the binding domains of THAP11 and PCBP1. (A) Schematic illustration of PCBP1 and its truncated fragments were shown as the upper panel. HEK293 cells
were cotransfected with the vectors just as indicated. Immunoprecipitation was performed with anti-Flag antibody. (B) Schematic illustration of THAP11 and its truncated
fragments were shown as the upper panel. HEK293 cells were cotransfected with the vectors just as indicated and then immunoprecipitation was performed with anti-Flag
antibody.
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tor according to the manufacturer’s instruction.
2.4. Co-immunoprecipitation
Cells were washed once in PBS, and lysed in 1 ml of lysis buffer
(50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100), and centrifuged for 15 min at 12,000 rpm at 4 C. Immuno-
precipitations were performed with anti-Myc afﬁnity gel (Sigma–
Aldrich, St. Louis, MO, USA) and then followed by Western blotting
analysis.
For detecting interaction of endogenous THAP11with PCBP1, cells
were lysed and immunoprecipitated with anti-THAP11 antibody
(R&D Systems) or sheep IgG. After extensive washing with the lysis
buffer, the immunoprecipitates were resolved by SDS–PAGE,
followed byWestern blot analysis using the anti-PCBP1 antibody.
2.5. Western blotting
For Western blotting, cells were lysed with M-PER

Mammalian
Protein Extraction Reagent (Pierce, Rockford, IL, USA). Western blot
analysis was performed according to standard procedures. Antibod-
ies were used at the following concentrations: PCBP1 antiserum,
1:1000; THAP11, 1:1000; anti-Myc (sc-40, Santa Cruz), 1:1000;
anti-Flag (F 3165, Sigma), 1:5000; GAPDH (Santa Cruz), 1:1000.
Chemiluminescent detectionwas conducted using supersignal sub-
strate (Pierce) according to the manufacturer’s speciﬁcations.
2.6. Confocal immunoﬂuorescence microscopy
Cells were grown on 10 mm glass coverslips, transfected with
pEGFP-THAP11 pDsRed-PCPB1 for 24 h, and then cells were ﬁxed
for 30 min at room temperature with 4% paraformaldehyde in
PBS and stained with Hoechst 33258. Confocal imaging was per-
formed using Zeiss 510 META system.
2.7. RNA interference (RNAi)
The small interfering RNA (siRNA) oligos of THAP11 were syn-
thesized in GenePharma Biotechnology as described previously[5], The PCBP1 siRNA oligos were synthesized as described
previously [14]. The negative control (non-silencing) siRNA were
obtained from Qiagen (Qiagen, Germantown, MD, USA). siRNA
were transfected into HepG2 cells using Lipofectamine 2000 (Invit-
rogen) at a concentration of 20 nM.
2.8. Reverse transcription-PCR (RT-PCR) and quantitative real-time
RT-PCR
Total RNA was reverse-transcribed and ampliﬁed using reverse
transcription and PCR (Promega Corp., Madison, WI, US) kits,
respectively. The PCR products were electrophoresed on 1% aga-
rose gels and photographed under ultraviolet light. Quantitative
real-time RT-PCR was done by ABI Prism 7700 Sequence Detector
(Applied Biosystems, Foster City, CA). The sequences of the primers
are provided in Supplementary Table S1.
2.9. Matrigel invasion assay
Biocoat Matrigel invasion chambers (Becton Dickinson) were
used to assess the invasiveness of HepG2 cells. 5  104 cells
were re-suspended in 250 ll of serum-free DMEM and added
to the cell culture inserts of the invasion chambers. Fetal bovine
serum (10%) was used as a chemoattractant and placed in the
lower wells. After 22–24 h, cells on the upper surface of the
membrane were removed using cotton swabs, and the ﬁlters
were ﬁxed by immersion in 4% formaldehyde for 10 min. After
two washes with water, the invaded cells were then stained
with 0.2% crystal violet. Excess dye was rinsed off two times
with water. The stained cells were photographed using a digital
camera and counted.
2.10. Statistical analysis
All experiments were performed at least three times. Data were
reported as means ± SD and the statistical signiﬁcance was as-
sessed by one-way analysis of variance (ANOVA) followed by the
two-sided Dunnett post hoc tests. A value of P < 0.05 was consid-
ered to be signiﬁcant. The Spearman correlation test was used to
analyze the correlation between parameters.
Fig. 3. THAP11 negatively regulates CD44 v6 expression. (A) PCBP1 or THAP11 expression vector was transfected into HepG2 cells for 24 h and total RNA were extracted for
semi-quantitative RT-PCR. The PCR bands were scanned for densitometry analysis with the value obtained from control cells set as 1. The values were normalized with those
of GAPDH (B). (C) Different doses of THAP11 expression vector were transfected into HepG2 cells for 24 h later and total RNA were extracted for semi-quantative PCR and
Real-time PCR analysis (D). The expression of THAP11 was analyzed by Western blotting. (E) HepG2 cells was transfected with a constitutively activated mutant H-Ras V12
construct along with THAP11 expression vector just as indicated (left). HepG2 cells was transfected with THAP11 expression vector for 24 h and then treated with 20 ng/ml
HGF for 8 h (Right). Total RNA were extracted for RT-PCR and Real-time PCR (F) analysis. (G) HepG2 cells were transfected with RNAi oligos as indicated for 72 h and then the
mRNA level of v6 was examined by semi-quantative PCR and Real-time PCR analysis (H). Statistical analysis was performed and the results represented mean ± SD of 3
independent experiments.
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3.1. Conﬁrmation of the Interaction between THAP11 and PCBP1
in vivo
To evaluate the interaction between THAP11 and PCBP1 in
mammalian cells, PCBP1 expression vector pCMV-Flag-PCBP1
was cotransfected into HEK293 cells with pcDNA3.1(His/Myc)-
THAP11 or pcDNA3.1(His/Myc) control vector, then immunopre-
cipitation was performed with anti-Myc antibody. As shown in
Fig. 1A, PCBP1 was speciﬁcally immunoprecipitated with THAP11.
In contrast, no PCBP1 protein was observed in immunoprecipitates
from cells transfected with PCBP1-Flag and pcDNA3.1(His/Myc).
The interaction between endogenous THAP11 and PCBP1 pro-
teins was further conﬁrmed in HepG2 cells. Immunoprecipitations
were performed with anti-THAP11 antibody using normal sheep
IgG as control. As shown in Fig. 1B, endogenous PCBP1 can be
immunoprecipitated by anti-THAP11 antibody. The possibility ofribosomal RNA or DNA mediating the binding was ruled out since
the binding was not altered when RNase A and DNase were in-
cluded throughout the cell lysis and immunoprecipitates.
To further conﬁrm this association, HepG2 cells were transfec-
ted with PCBP1-RFP and THAP11-GFP vectors. The localizations
of THAP11 (green) and PCBP1 (red) were observed through confo-
cal imaging. As shown in the Fig. 3C, PCBP1 mainly localizes in
cytoplasm with a smaller nuclear diffuse fraction in normal condi-
tions, while THAP11 is a nuclear diffuse protein. However, co-
expression of THAP11 led to PCBP1 proteins shuttling from cyto-
plasm into nucleus (Fig. S1) and accordingly, THAP11 and PCBP1
showed a partial co-localization in nucleus.
3.2. Mapping the binding domains of THAP11 and PCBP1
To determine which domain of PCBP1 is required for THAP11/
PCBP1 interaction, full-length and deletion mutants of PCBP1
expression vector were transfected into HEK293 cells with
Fig. 4. The regulation of v6 expression by THAP11 is mediated through binding to PCBP1. (A) HepG2 cells were co-transfected with siRNA and expression vectors as indicated
for 72 h and then total RNA were extracted for semi-quantative RT-PCR and real-time PCR analysis (B). (C) HepG2 cells were transfected with THAP11 or its deletion mutants
for 24 h and total RNA was extracted for semi-quantative RT-PCR and real-time PCR analysis (D). The values were normalized with those of GAPDH. Statistical analysis was
performed and the results represented mean ± SD of 3 independent experiments.
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formed. As shown in Fig. 2A, THAP11 can be co-immunoprecipated
by PCBP1, N83, C273, while no signal was detected in the immuno-
precipitates from cells transfected with C184, suggesting that the
ﬁrst two KH domains (KH1 and KH2) are required for THAP11
binding.
To determine the binding domain of THAP11 with PCBP1,
HEK293 cells were transfected with the vectors as Fig. 2B indi-
cated. Immunoprecipitations was performed using anti-FLAG anti-
body. As Fig. 2B shows, the C-terminal 182aa (131–313) of THAP11
was sufﬁcient to interact with PCBP1.
3.3. THAP11 negatively regulates CD44 v6 expression
As our previous study shows, PCBP1 overexpression inhibited
CD44 v2, v3, v6, v7, v8, and v10 expression [14]. We investigated
whether THAP11 regulated these variants expression. HepG2 cells
were co-transfected vectors as Fig. 3A indicated and the levels of
CD44 variants were measured by RT-PCR. As shown in Fig. 3A
and B, THAP11 overexpression reduced the expression of v3, v6,
and v8 signiﬁcantly and co-expression of PCBP1 synergistically
inhibited these variants expression. No signiﬁcant effect was ob-
served of THAP11 on v7, v9, v10 and standard form (std)
expression.
We investigated the role of THAP11 in regulating CD44 v6
expression in more details. Different doses of THAP11 expression
vectors was transfected into HepG2 cells and then the CD44 v6 le-
vel was measured by RT-PCR (Fig. 3C) and real-time PCR (Fig. 3D).
The results suggested that THAP11 inhibited the CD44 v6 expres-
sion in a dose-dependent manner. The similar results were ob-
tained in another hepatocellular carcinoma cell line SMMC-7721
cells (Fig. S2) and human colon cancer cell line HCT116 cells
(Fig. S3). As previously reported, Ras activation or HGF stimulation
led to induction of CD44 v6 expression [15]. As shows in Fig. 3E and
F, THAP11 overexpression signiﬁcantly inhibited Ras or HGF-in-
duced CD44 v6 expression.To conﬁrm the physiological function of THAP11 in regulating
CD44 v6 splicing, THAP11 siRNA or control siRNA was transfected
with HepG2 cells. As Fig. 3G and H show, the expression level of
CD44 v6 was increased in cells transfected with THAP11 siRNAs
compared to negative control. These results indicated that THAP11
negatively regulated the CD44 variants expression.
3.4. The regulation of CD44 variants expression by THAP11 is mediated
through binding to PCBP1
To examine the role of THAP11/PCBP1 interaction in the regula-
tion of CD44 v6 expression, we blocked the interaction in vivo by
RNAi. As shown in Fig. 4A and B, knockdown of endogenous PCBP1
attenuated the inhibition effect of THAP11 on CD44 v6 expression,
whereas in the presence of THAP11 siRNA, PCBP1 still had signiﬁ-
cant inhibition effect on CD44 v6 expression. We further analyzed
the effect of deletion mutants of THAP11 on v6 expression. As
shown in Fig. 4C and D, the deletion mutant N137 which abolished
the interaction with PCBP1 lost the inhibition effect on v6 expres-
sion while the deletion mutants C182 and C227 still inhibited the
v6 expression signiﬁcantly. These data suggest that THAP11 inhib-
ited CD44 v6 expression depending on the interaction with PCBP1.
3.5. THAP11 inhibits HepG2 cell invasion
We further investigated whether THAP11 affected the tumor
cell invasion. PCBP1 or THAP11 expression vector was transfected
into HepG2 cells and cell invasion was measured. The cell invasion
of PCBP1 transfected cells was about 67% of the control cells, while
THAP11 overexpression led to about 52% decrease of the cell inva-
sion compared to the control (Fig. 5A and B). Co-expression of
THAP11 and PCBP1 led to almost 90% reduction of cell invasion,
suggesting a synergistic effect between THAP11 and PCBP1. The
similar results were obtained in SMMC-7721 cells (Fig. S4) and
HCT116 cells (Fig. S5). To conﬁrm the effect of THAP11 on cell inva-
sion, endogenous THAP11 was knockdown by RNAi and then cell
Fig. 5. Negative role THAP11 in tumor cell invasion. (A)THAP11 inhibits the invasion of hepatoma cells synergistically with PCBP1. HepG2 cells were transfected with the
vectors just as indicated for 24 h. Quantitation of tumor cell invasion was shown as (B). The percentage of cell invasion was normalized to that of cells transfected with control
vector. (C) Invasion assays of HepG2 cell transfected with RNAi oligos as indicated. Quantitation of tumor cell invasion was shown as (D). The percentage of cell invasion was
normalized to that of cells transfected with N.C. Statistical analysis was performed and the results represented mean ± SD of 3 independent experiments. (E) Correlation of
THAP11 and PCBP1 mRNA expression in HCC and corresponding non-tumorous liver tissue samples. The expression levels of PCBP1 and THAP11 in non-cancerous tissues
were set to 1 and normalized to GAPDH mRNA. The experiments in each sample were performed in triplicate with at least 3 independent times. The data was shown as the
average of these experiments. Then Spearman test was performed.
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THAP11 in HepG2 cells led to about 2.1-fold increased of cell inva-
sion. The similar results were obtained in SMMC-7721 cells (data
not shown). These results suggested that THAP11 negatively regu-
lated tumor cell invasion, which is similar to PCBP1.3.6. Cooperation of THAP11 mRNA and PCBP1 mRNA expression in
HCC
Since both PCBP1 and THAP11 are negative regulators in tumor
cell invasion and down-regulated in HCC tissues, we further
W.-X. Lian et al. / FEBS Letters 586 (2012) 1431–1438 1437examined whether a correlation of the expression pattern of
THAP11 and PCBP1 exists in primary HCC. Real-time PCR analysis
was performed to detect the mRNA levels of THAP11 and PCBP1
(Fig. S6) in HCC tissues and the adjacent non-cancerous liver tissues
of 33HCCpatients. The result suggested that inHCC tissues, THAP11
mRNA expression showed signiﬁcant correlation with the expres-
sion of PCBP1 mRNA (n = 33, r = 0.847, p < 0.001) (Fig. 5C).4. Discussion
THAP11 is the mostly recently identiﬁed member of THAP fam-
ily, although several studies have suggested its essential roles in
cell growth and ES cells pluripotency, its function still remains lar-
gely unknown. In our present study, we ﬁrst provide evidence that
THAP11 inhibits CD44 variant splicing including v3, v6 and v8. The
over-expression of CD44 v6 has been widely reported in a vast
number of primary tumors and metastases, making it to be an
attractive target for antibody-guided therapy of various types of
cancers [16,17]. We investigate the effect of THAP11 on v6 expres-
sion in detail. Overexpression of THAP11 in HepG2 cells can inhibit
the v6 expression induced by Ras activation and HGF, and knock-
down of endogenous THAP11 led to increased level of v6 mRNA.
Furthermore, overexpression of THAP11markedly inhibited the tu-
mor cell invasion while knockdown of THAP11 increased the cell
invasion. These results indicate that THAP11 is a novel negative
regulator of CD44 variant splicing and tumor cell invasion.
Since no evidence suggests that THAP11 has the activity of
binding RNA, it is easy to hypothesize that THAP11 regulates v6
splicing by association with other trans-acting factors. In our pre-
vious study, we identiﬁed PCBP1 as a novel binding protein of
THAP11 using yeast two-hybrid screening. In this study, we con-
ﬁrmed the interaction between THAP11 and PCBP1 in vivo by co-
immunoprecipitation and colocalization assay. PCBP1, a mRNA
binding and regulatory protein, belongs to the hnRNP family pro-
teins [18] which are non-core components of human spliceosomal
complex and presumably link the spliceosome to other cellular
machineries such as transcription factors, spliceosomal factors as
well as proteins that copurify reproducibly but are present in very
low amounts [19]. It has been reported that speciﬁc binding of
PCBP1 to U1 small nuclear ribonucleoprotein (snRNP) in the pre-
spliceosomal complex was associated with silencing of pseudoex-
on splicing of growth hormone receptor [20]. Our recent study sug-
gests that PCBP1 negatively regulates CD44 alternative splicing in
an exon-speciﬁc manner, possibly in association with other partner
proteins [14]. In this study, we found that THAP11 inhibits the
CD44 v6 splicing in a PCBP1-dependent manner. Co-expression of
THAP11 and PCBP1 in HepG2 cells showed synergistic inhibition
effect on the CD44 v6 expression and cell invasion. A correlation
of THAP11 and PCBP1 mRNA expression pattern was observed in
HCC tissues. Consistent with this, THAP11 inhibits speciﬁc variant
splicing including v3, v6 and v8, which is very similar to the pat-
tern of PCBP1. These data suggest that THAP11/PCBP1 interaction
play key roles in CD44 alternative splicing. Then an interesting
question is raised: what is the molecular basis for THAP11/PCBP1
interaction to regulate alternative splicing? In a recent study of dy-
namic protein–protein interaction (PPI) network of human splice-
osome, 632 unique PPIs were obtained [21]. Among these PPIs,
PCBP1 was shown to interact with hPRP8 and PPIG. The U5 protein
hPRP8 together with hBRR2 and hSNU114 are major core compo-
nents of the spliceosome and play essential roles at several steps
of splicing. PPIG is a regulatory protein of mRNA splicing through
modulating the functions of SR-like and SR splicing factors. These
data raise the possibility that THAP11 might be recruited to the
spliceosomal complex by PCBP1 and then plays roles in mRNA
splicing. However, further studies aimed at unraveling themechanism of action are needed. More interestingly, PCBP1 has
been recently reported to inhibit the metastasis of colon cancer
cells through suppressing the translation of metastasis-associated
PRL-3 phosphatase [22]. Our present study shows that THAP11 also
negatively inhibits cell invasion of human colon cancer cell line
HCT116 cells. Whether THAP11 regulates the PRL-3 translation
and whether the expression level of THAP11 is associated with
PCBP1 expression level in other types of cancer patients such as co-
lon cancer remain to be determined.
In this study, we provide the ﬁrst line of evidence that THAP11
is a novel physiological binding partner of PCBP1. In HepG2 cells,
THAP11 inhibits the CD44 v6 expression depending on the interac-
tion with PCBP1. THAP11 negatively regulates tumor cell invasion
in a synergistic mechanism with PCBP1 and in HCC patients, the
expression of THAP11 mRNA is signiﬁcantly correlated with PCBP1
mRNA expression. Our results suggest a novel role of THAP11 in
CD44 alternative splicing and hepatocellular carcinoma invasion.
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